Iovance Biotherapeutics Inc: Baird assumes coverage with neutral rating; target price $6
IOVA•Related News
Nasdaq trade halt continues <SVA.O> reason not available at 03:28 AM
SVA•
Happen director Erin Selleck sells 2,057 common shares worth $35,815.37
HAPN•
Chrysler Is Recalling 328,381 U.S. Vehicles - NHTSA
STLA•
Nasdaq trade halt continues <AIXI.O> halt news pending at 03:28 AM
AIXI•
Nasdaq Trade Halt Continues <PC.O> Reason Not Available at 07:50 PM
PC•